Heart failure & cardiomyopathies
A Nationwide, Population-Based Study on Specialized Care for Acute Heart Failure Throughout the COVID-19 Pandemic
Main finding · Long-term outcomes over timeResult — go to the resultHazard ratio 0.92 95% CI 0.90–0.95Authors' conclusion
Despite the disruption of healthcare systems, the clinical characteristics of patients admitted with HF were similar and the overall standard of care was maintained throughout the pandemic. Long-term survival of patients hospitalized with HF continued to improve after COVID-19, especially for HFrEF.
Study context
- Population
- Patients admitted to hospital with heart failure (HF), National Heart Failure Audit linked to national hospitalization and death records51% HFrEF (n = 116,990)
- Participants
- 227,250 patients
- Exposure
- Pre-COVID vs COVID vs late/post-COVID periods
- Outcome
- Long-term outcomes over time
Methodological detailsnationwide, population-based, registry linkage
- Nationwide
- Population-based
- Registry linkage
Main finding
As reported in the abstract
Hazard ratio
0.92
95% CI 0.90–0.95
P < 0.001
Over time
HR 0.92 (95% CI 0.90–0.95); P < 0.001
- In-hospital management and specialized cardiology care maintained; increasing % discharged on disease-modifying medications over time
- P < 0.001
Observational data: associations, not effects.
Further findings
Long-term outcomes with specialized cardiology care, by HF type
| HR (95% CI) | P value | ||
|---|---|---|---|
| Specialized cardiology careHFrEF | 0.79 (0.77–0.82) | P < 0.001 | |
| Specialized cardiology carenon-HFrEF | 0.87 (0.85–0.90) | P < 0.001 | |
| 0.512Hazard ratio (log scale) |
Original publication
A Nationwide, Population-Based Study on Specialized Care for Acute Heart Failure Throughout the COVID-19 Pandemic. Eur J Heart Fail. Published 4 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →